(Q45415648)

14 December 2017

title

Therapeutic options in BK virus-associated interstitial nephritis (English)

1 reference

14 December 2017

Crew RJ

1

1 reference

14 December 2017

Markowitz G

series ordinal

2

1 reference

14 December 2017

Radhakrishnan J

series ordinal

3

1 reference

14 December 2017

language of work or name

English

0 references

publication date

14 June 2006

1 reference

14 December 2017

1 reference

14 December 2017

volume

70

1 reference

14 December 2017

issue

2

1 reference

14 December 2017

page(s)

399-402

1 reference

New human papovavirus (B.K.) isolated from urine after renal transplantation

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001540

7 January 2021

Native kidney BK nephropathy post cardiac transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001540

7 January 2021

Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001540

7 January 2021

Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001540

7 January 2021

Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001540

7 January 2021

Human polyomavirus (BK) infection and ureteric stenosis in renal allograft recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001540

7 January 2021

Human polyoma virus-associated interstitial nephritis in the allograft kidney

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001540

7 January 2021

BK virus-associated nephropathy in renal allograft recipients: rescue therapy by sirolimus-based immunosuppression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001540

7 January 2021

BK nephropathy in kidney transplant recipients treated with a calcineurin inhibitor-free immunosuppression regimen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001540

7 January 2021

Dendritic cells pulsed with polyomavirus BK antigen induce ex vivo polyoma BK virus-specific cytotoxic T-cell lines in seropositive healthy individuals and renal transplant recipients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001540

7 January 2021

Treatment of BK virus-associated hemorrhagic cystitis and simultaneous CMV reactivation with cidofovir

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001540

7 January 2021

Treatment of polyomavirus infection with cidofovir in a renal-transplant recipient

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001540

7 January 2021

Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001540

7 January 2021

Inhibition of herpes simplex virus type 1 by the experimental immunosuppressive agent leflunomide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001540

7 January 2021

Leflunomide for polyomavirus type BK nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001540

7 January 2021

Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001540

7 January 2021

Retransplantation in patients with graft loss caused by polyoma virus nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001540

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5001540

1 reference

Dimensions Publication ID

14 December 2017

1031710289

0 references

1 reference